Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FunPep CoTSE:4881 +2.04%50 PS Ratio is 1,136.36 as of Sep. 21, 2026, which is 75% below its 10-year median of 4,466.67. GuruFocus rates TSE:4881 with a GF Score™ of 50/100 and a GF Value™ of 円156.75 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 938 Biotechnology companies, FunPep Co ranks worse than 96.16% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, FunPep Co's share price is 円50.00.
FunPep Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was 円0.04. Hence, FunPep Co's PS Ratio for today is 1,136.36.
Good Sign:
FunPep Co Ltd stock PS Ratio (=1062.5) is close to 3-year low of 958.33.
The historical rank and industry rank for FunPep Co's PS Ratio or its related term are showing as below:
TSE:4881'
s PS Ratio Range Over the Past 10 Years
Min: 27.32 Med: 4466.67 Max: 58500
Current: 1041.67
During the past 9 years, FunPep Co's highest PS Ratio was 58500.00. The lowest was 27.32. And the median was 4466.67.
TSE:4881's PS Ratio is ranked worse than 96.16% of 938
companies
in the Biotechnology industry
Industry Median: 9.375
vs TSE:4881: 1041.67
FunPep Co Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of FunPep Co was 700.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -47.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -55.50% per year.
During the past 9 years, FunPep Co's highest 3-Year average Revenue per Share Growth Rate was -30.70% per year. The lowest was -87.10% per year. And the median was -60.25% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
FunPep Co PS Ratio Related Terms
FunPep Co PS Ratio Historical Data
* Premium members only.
The historical data trend for FunPep Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, FunPep Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FunPep Co PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, FunPep Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where FunPep Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
FunPep Co's Share Price of today is 円50.00. FunPep Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
FunPep Co (TSE:4881) has a PS Ratio of 1,136.36 as of Sep. 21, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on FunPep Co and its competitors. This is 75% below median its historical median of 4,466.67. Over the past decade, FunPep Co's PS Ratio has ranged from 27.32 to 58,500.00. According to the industry distribution chart, FunPep Co ranks #902 out of 938 companies in the Biotechnology industry, placing it in the top 96.2%.
Is FunPep Co's PS Ratio too high?
FunPep Co's current PS Ratio of 1,136.36 is 75% below median its 10-year median of 4,466.67. Over the past 10 years, this metric has ranged from a low of 27.32 to a high of 58,500.00. The Biotechnology industry median PS Ratio is 9.38. FunPep Co's value of 1,136.36 is 12021.2% above this industry median. Based on the distribution chart, FunPep Co ranks #902 out of 938 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, FunPep Co has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does FunPep Co's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, FunPep Co ranks #902 out of 938 companies for PS Ratio. This places FunPep Co in the lower half of its industry. The industry median PS Ratio is 9.38. FunPep Co's value of 1,136.36 is 12021.2% above this benchmark. Historically, FunPep Co's own PS Ratio has ranged from 27.32 to 58,500.00 over the past decade. While the company's 10-year median is 4,466.67 vs. the industry median of 9.38, FunPep Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.38, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. FunPep Co's current PS Ratio of 1,136.36 is 12021.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on FunPep Co and its competitors. For the Biotechnology industry, the median PS Ratio is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FunPep Co's current PS Ratio is 1,136.36, which is 75% below median its own 10-year median of 4,466.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FunPep Co stock overvalued right now?
Based on GuruFocus' analysis, FunPep Co (TSE:4881) is currently considered Possible Value Trap. The stock's GF Value™ is 円156.75, compared to a current price of 円50.00 — trading 68.1% below its estimated fair value. The current PS Ratio is 1,136.36, which is 75% below median its 10-year median of 4,466.67 and 12021.2% above the Biotechnology industry median of 9.38. FunPep Co's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For FunPep Co (TSE:4881), the current PS Ratio is 1,136.36 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is FunPep Co (TSE:4881) Overvalued in 2026?
Based on GuruFocus' analysis, FunPep Co stock appears to be undervalued.
The current stock price of 円50.00 is trading 68.1% below its estimated GF Value™ of 円156.75.
GuruFocus considers FunPep Co to be Possible Value Trap.
Key valuation signals for TSE:4881:
PS Ratio: 1,136.36 (75% below median its 10-year median of 4,466.67)
GF Value™: 円156.75 vs. price of 円50.00 (68.1% below fair value)
Industry Position: 12021.2% above the Biotechnology median (#902 of 938)
No single metric tells the full story. See the TSE:4881 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
FunPep Co Ltd is a biotechnology company focused on the functions of peptides to develop business from cosmetics to medical devices and pharmaceutical products. The company develops drugs related to the intractable peptic ulcer disease. The Group operates in a single segment, which is the research and development of pharmaceuticals.
50GF Score
Get the complete analysis for TSE:4881
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4881 has been successfully added to your 
